140 related articles for article (PubMed ID: 2890808)
1. Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers.
McDonald EM; Mann AH; Thomas HC
Lancet; 1987 Nov; 2(8569):1175-8. PubMed ID: 2890808
[TBL] [Abstract][Full Text] [Related]
2. Lymphoblastoid and recombinant alpha-A interferon therapy of chronic hepatitis B virus infection. The Royal Free Hospital experience.
Thomas HC; Scully LJ; McDonald JA
J Hepatol; 1986; 3 Suppl 2():S193-7. PubMed ID: 3298407
[TBL] [Abstract][Full Text] [Related]
3. Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies.
Scully LJ; Lever AM; Yap I; Pignatelli M; Thomas HC
J Hepatol; 1986; 3 Suppl 2():S291-9. PubMed ID: 2439575
[TBL] [Abstract][Full Text] [Related]
4. Recombinant alpha 2-interferon treatment in children with chronic hepatitis B.
La Banda F; Ruiz Moreno M; Carreño V; Bartolome J; Gutiez J; Ramon y Cajal S; Moreno A; Mora I; Carlos Porres J
Lancet; 1988 Jan; 1(8579):250. PubMed ID: 2893078
[No Abstract] [Full Text] [Related]
5. Recombinant fibroblast interferon and immune interferon for treating chronic hepatitis B virus infection: patients' tolerance and the effect on viral markers.
Bissett J; Eisenberg M; Gregory P; Robinson WS; Merigan TC
J Infect Dis; 1988 May; 157(5):1076-80. PubMed ID: 3129521
[No Abstract] [Full Text] [Related]
6. A randomised controlled trial with human lymphoblastoid interferon vs no treatment in chronic hepatitis B virus infection. Preliminary results.
Barbara L; Mazzella G; Baraldini M; Gasbarrini G; Giungi F; Malavolti M; Mastroroberto L; Miglio F; Roda E; Raise E
J Hepatol; 1986; 3 Suppl 2():S235-8. PubMed ID: 3298411
[No Abstract] [Full Text] [Related]
7. [Antiviral treatment of chronic active hepatitis B. Combination therapy with beta interferon and recombinant gamma interferon].
Eisenburg J; Caselmann W; Eder M; Pape GR
Fortschr Med; 1988 Jul; 106(21):431-7. PubMed ID: 3146536
[No Abstract] [Full Text] [Related]
8. The treatment of chronic type B viral hepatitis.
Aach RD
Ann Intern Med; 1988 Jul; 109(2):89-91. PubMed ID: 3289432
[No Abstract] [Full Text] [Related]
9. Human lymphoblastoid interferon for the treatment of chronic hepatitis B. A randomized controlled trial.
Mazzella G; Saracco G; Rizetto M; Amed MA; Gonzàlez Quintela A; Rosina F; Barbara L; Roda E
Am J Med; 1988 Aug; 85(2A):141-2. PubMed ID: 3044077
[TBL] [Abstract][Full Text] [Related]
10. Interferon in chronic active hepatitis B. Preliminary results.
Waked I; Amin M; Abd-el Fattah SA; Osman L; Sabbour M
Chemioterapia; 1988 Jun; 7(3):198-202. PubMed ID: 3168077
[TBL] [Abstract][Full Text] [Related]
11. Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B.
Anderson MG; Harrison TJ; Alexander GJ; Zuckerman AJ; Murray-Lyon IM
J Hepatol; 1986; 3 Suppl 2():S225-7. PubMed ID: 3298409
[TBL] [Abstract][Full Text] [Related]
12. [Subclasses of antibodies to hepatitis B core antigen in chronic HBV infections: changes during treatment with interferons and predictors of response].
Cheng GM; Karayiannis P; Thomas HC
Zhonghua Nei Ke Za Zhi; 1990 Mar; 29(3):141-3, 188-9. PubMed ID: 1698593
[TBL] [Abstract][Full Text] [Related]
13. Combination of recombinant interferons alpha and gamma in treatment of chronic hepatitis B.
Carreno V; Mora I
Lancet; 1987 Nov; 2(8567):1086. PubMed ID: 2889990
[No Abstract] [Full Text] [Related]
14. Antiviral treatment in chronic hepatitis B. Data of 5 prospectively controlled randomized trials.
Müller R; Klein H; Vido I; Niehoff G; Lautz HU; Gebel M; Schmidt FW
J Hepatol; 1986; 3 Suppl 2():S217-23. PubMed ID: 2439573
[No Abstract] [Full Text] [Related]
15. Activation of liver disease in healthy hepatitis B surface antigen carriers during interferon-alpha treatment.
Rodríguez-Iñigo E; Bartolomé J; López-Alcorocho JM; Contonat T; Oliva H; Carreño V
J Med Virol; 1997 Sep; 53(1):76-80. PubMed ID: 9298736
[TBL] [Abstract][Full Text] [Related]
16. Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children.
Lai CL; Lok AS; Lin HJ; Wu PC; Yeoh EK; Yeung CY
Lancet; 1987 Oct; 2(8564):877-80. PubMed ID: 2889081
[TBL] [Abstract][Full Text] [Related]
17. Lymphoblastoid interferon in controlled trials of chronic hepatitis B virus infection.
Hadziyannis SJ
Hepatology; 1988; 8(3):696-8. PubMed ID: 3286465
[No Abstract] [Full Text] [Related]
18. [Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant alpha-A-interferon. Results of a phase II study].
Hess G; Weber C; Rossol S; Voth R; Drees N; Meyer zum Büschenfelde KH
Z Gastroenterol; 1988 Jul; 26(7):380-7. PubMed ID: 3223006
[TBL] [Abstract][Full Text] [Related]
19. Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus.
Brook MG
Lancet; 1988 Oct; 2(8618):1017-8. PubMed ID: 2902445
[No Abstract] [Full Text] [Related]
20. Treatment of chronic delta hepatitis with alpha-2 recombinant interferon.
Rizzetto M; Rosina F; Saracco G; Bellando PC; Actis GC; Bonino F; Smedile A; Trinchero P; Sansalvadore F; Pintus C
J Hepatol; 1986; 3 Suppl 2():S229-33. PubMed ID: 3298410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
